| Hans-Günter Meyer-Thompson | HIV
Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
Cora L. Bernard, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert, Margaret L. Brandeau.
PLOS Medicine, 2017; 14 (5): e1002312 DOI: 10.1371/journal.pmed.1002312
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002312